-
-
-
-
-
-
-
Intercept Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis due to NASH
-
-
-
-
-
-
-
Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates; Issues 2023 Financial Guidance
-
-
-
-
-
-
-
Intercept Pharma (ICPT) Provides Update on NASH Regulatory Timeline, Pre-submission Meeting Moved to July
-
-
-
-
-
-
-
Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results, Issues 2022 Financial Guidance and Provides Business Update
-
-
-
-
-
-
-
Intercept Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Intercept Appoints Andrew Saik as Chief Financial Officer
-
-
-
-
-
-
-
Intercept Pharma (ICPT) Announces Dagmar Rosa-Bjorkeson to Board
-
13,124 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All